
    
      With optimized therapeutic protocol we would prevent progression of the dry form of AMD into
      its devastating wet form and stabilize the situation. We suppose that retinal morphologic and
      functional conditions would improve in a high percentage of patients. Also possible technical
      and economic savings would not be less important with our own therapeutic protocol,
      especially, when blindness could be prevented.
    
  